# TGFBRAP1

## Overview
TGFBRAP1, or Transforming Growth Factor Beta Receptor Associated Protein 1, is a gene that encodes a chaperone protein involved in the TGF-β signaling pathway. This protein plays a pivotal role in cellular processes such as growth, differentiation, and apoptosis by facilitating the interaction between Smad4 and receptor-activated Smad proteins, including Smad2 and Smad3. As a chaperone, TGFBRAP1 is crucial for the translocation of these complexes to the nucleus, where they regulate gene transcription (Wurthner2001Transforming). The protein is active in both the cytoplasm and nucleus, influencing immune response and tissue homeostasis (Wurthner2001Transforming). TGFBRAP1's interactions with TGF-β receptor complexes and its modulation of TGF-β signaling underscore its importance in maintaining cellular and tissue equilibrium, with implications for organismal development and disease prevention (Guo2015Polymorphisms).

## Function
TGFBRAP1, also known as Transforming Growth Factor Beta Receptor Associated Protein 1, functions as a chaperone in the TGF-β signaling pathway, which is crucial for regulating cell growth, differentiation, and apoptosis. It primarily acts by facilitating the interaction of Smad4 with receptor-activated Smad proteins, such as Smad2 and Smad3, thereby promoting the translocation of these complexes to the nucleus to regulate gene transcription (Wurthner2001Transforming). TGFBRAP1 is active in both the cytoplasm and nucleus, where it influences various cellular processes, including immune response and tissue homeostasis (Wurthner2001Transforming).

In healthy human cells, TGFBRAP1 associates with inactive TGF-β receptor complexes, particularly type II receptors, and dissociates upon receptor activation, indicating its role in modulating signal transduction (Wurthner2001Transforming). The protein's interaction with Smad4 is transient and is disrupted by the presence of activated Smad2, suggesting a regulatory mechanism that ensures precise control of TGF-β signaling (Wurthner2001Transforming). This modulation of TGF-β signaling by TGFBRAP1 is essential for maintaining cellular and tissue homeostasis, impacting organismal development and disease prevention (Guo2015Polymorphisms).

## Clinical Significance
Mutations and alterations in the expression of the TGFBRAP1 gene have been implicated in several diseases, particularly type 2 diabetes mellitus (T2DM) and pulmonary fibrosis. The rs2241797 polymorphism in TGFBRAP1 is significantly associated with an increased risk of T2DM. This variant affects glucose levels and insulin secretion, potentially through epigenetic mechanisms and interactions with diabetes-related microRNAs (Yang2018The). The study also highlights the joint effect of rs2241797 with other SNPs, such as rs749794, suggesting a dose-response relationship that could inform individualized drug therapy for T2DM (Yang2018The).

In the context of pulmonary fibrosis, TGFBRAP1 plays a critical role in the TGF-β/SMAD7 signaling pathway. It interacts with Chitinase 1 (CHIT1) to enhance TGF-β1-stimulated fibrotic responses by modulating SMAD7 expression. This interaction is crucial for the progression of fibrotic diseases like idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease (Lee2019Chitinase). Alterations in TGFBRAP1 expression, as part of the CHIT1-mediated pathway, may contribute to the pathogenesis of these fibrotic conditions (Lee2019Chitinase).

## Interactions
TGFBRAP1, or transforming growth factor beta receptor associated protein 1, is involved in several key interactions within the TGF-β signaling pathway. It primarily acts as a chaperone for Smad4, facilitating its interaction with receptor-activated Smad proteins such as Smad2 and Smad3. This interaction is crucial for the transduction of TGF-β signals, as Smad4 forms complexes with phosphorylated Smad2/3, which then translocate to the nucleus to regulate gene expression (Wurthner2001Transforming).

TGFBRAP1 also interacts with inactive TGF-β receptor complexes, particularly associating with type II receptors like TβRII. This interaction is stronger with kinase-deficient receptors, suggesting a role in regulating receptor activation states (Wurthner2001Transforming).

In the context of pulmonary fibrosis, TGFBRAP1 interacts with Chitinase 1 (CHIT1) and FOXO3, enhancing TGF-β1-stimulated fibrotic responses by modulating the expression of SMAD7, an inhibitory Smad protein. This interaction suggests a role for TGFBRAP1 in fine-tuning TGF-β signaling and contributing to fibrotic disease progression (Lee2019Chitinase).


## References


[1. (Lee2019Chitinase) Chang-Min Lee, Chuan-Hua He, Jin Wook Park, Jae Hyun Lee, Suchitra Kamle, Bing Ma, Bedia Akosman, Roberto Cotez, Emily Chen, Yang Zhou, Erica L Herzog, Changwan Ryu, Xueyan Peng, Ivan O Rosas, Sergio Poli, Carol Feghali Bostwick, Augustine M Choi, Jack A Elias, and Chun Geun Lee. Chitinase 1 regulates pulmonary fibrosis by modulating tgf-β/smad7 pathway via tgfbrap1 and foxo3. Life Science Alliance, 2(3):e201900350, May 2019. URL: http://dx.doi.org/10.26508/lsa.201900350, doi:10.26508/lsa.201900350. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.201900350)

[2. (Guo2015Polymorphisms) Daoxia Guo, Chong Shen, Yanchun Chen, Song Yang, Linhong Wang, Yuelong Jin, Lianping He, Jinfeng Chen, Xianghai Zhao, Wei Zhou, Hailong Zhao, and Yingshui Yao. Polymorphisms of the tgfbrap1 gene in relation to blood pressure variability and plasma tgf-β1. Clinical and Experimental Hypertension, 37(5):420–425, April 2015. URL: http://dx.doi.org/10.3109/10641963.2015.1013113, doi:10.3109/10641963.2015.1013113. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/10641963.2015.1013113)

[3. (Wurthner2001Transforming) Jens U. Wurthner, David B. Frank, Angelina Felici, Harry M. Green, Zhouhong Cao, Michael D. Schneider, James G. McNally, Robert J. Lechleider, and Anita B. Roberts. Transforming growth factor-β receptor-associated protein 1 is a smad4 chaperone. Journal of Biological Chemistry, 276(22):19495–19502, June 2001. URL: http://dx.doi.org/10.1074/jbc.m006473200, doi:10.1074/jbc.m006473200. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m006473200)

[4. (Yang2018The) Song Yang, Xiaotian Chen, Mengyao Yang, Xianghai Zhao, Yanchun Chen, Hailong Zhao, Chunlan Liu, and Chong Shen. The variant at <scp>tgfbrap</scp>1 is significantly associated with type 2 diabetes mellitus and affects diabetes‐related mi<scp>rna</scp> expression. Journal of Cellular and Molecular Medicine, 23(1):83–92, November 2018. URL: http://dx.doi.org/10.1111/jcmm.13885, doi:10.1111/jcmm.13885. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.13885)